Replies to post #96906 on Biotech Values

[DewDiligence]

FDA grants priority review for Merck KGaA’s Cladribine in RRMS:

http://www.reuters.com/article/idCNN2720940320100727

The PDUFA date is on or about 12/5/10 (Merck KGaA is not disclosing the exact date).

A decision on Cladribine from the EMA is expected in 3Q10. The MAA was submitted in Jul 2009 (#msg-39836037).